Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations
Ruaro, Barbara
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations - Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 - 1 electronic resource (178 p.)
Open Access
This e-book summarises the latest advances in the rheumatic diseases with a focus on the recent efforts of vascular and pulmonary manifestations and anticipate the new and future directions of these research topic. Rheumatic diseases represent a heterogeneous group of severe autoimmune disorders. The present Special Issue aims to provide an overview of the complexity of vascular and pulmonary manifestations of rheumatologic diseases and helps in knowledge to manage them. The eleven published articles here collected underline the complexity of rheumatic diseases and the difficult to treated them. The manuscripts provide an overview of the pathophysiology and current treatment regimes of these disorders, highlighting tools which assist with diagnosis, risk stratification and therapy. Finally, we underline the importance of a multidisciplinary team working using the skills of clinicians, radiologists, and pathologists.
Creative Commons
English
books978-3-0365-3642-2 9783036536415 9783036536422
10.3390/books978-3-0365-3642-2 doi
Medicine
Pharmacology
systemic sclerosis scleroderma interstitial lung disease pulmonary function tests high-resolution computed tomography rheumatic pulmonary arterial hypertension targeted therapy systemic lupus erythematosus airway disease shrinking lung syndrome diffuse alveolar hemorrhage pleurisy infection cardiopulmonary exercise testing osteopontin connective tissue diseases pulmonary involvement microvascular involvement nailfold capillaroscopy rheumatoid arthritis interstitial lung diseases CX3CL1/fractalkine CX3CR1 M1 macrophage M2 macrophage SKG mice heart failure 3D-echocardiography ventricular function outcome ventricular-arterial coupling antifibrotic agents COVID-19 IPF progressive fibrosing ILD UIP pharmacological interactions fibromyalgia gastrointestinal symptoms probiotic VSL#3® efficacy tolerability polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations - Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 - 1 electronic resource (178 p.)
Open Access
This e-book summarises the latest advances in the rheumatic diseases with a focus on the recent efforts of vascular and pulmonary manifestations and anticipate the new and future directions of these research topic. Rheumatic diseases represent a heterogeneous group of severe autoimmune disorders. The present Special Issue aims to provide an overview of the complexity of vascular and pulmonary manifestations of rheumatologic diseases and helps in knowledge to manage them. The eleven published articles here collected underline the complexity of rheumatic diseases and the difficult to treated them. The manuscripts provide an overview of the pathophysiology and current treatment regimes of these disorders, highlighting tools which assist with diagnosis, risk stratification and therapy. Finally, we underline the importance of a multidisciplinary team working using the skills of clinicians, radiologists, and pathologists.
Creative Commons
English
books978-3-0365-3642-2 9783036536415 9783036536422
10.3390/books978-3-0365-3642-2 doi
Medicine
Pharmacology
systemic sclerosis scleroderma interstitial lung disease pulmonary function tests high-resolution computed tomography rheumatic pulmonary arterial hypertension targeted therapy systemic lupus erythematosus airway disease shrinking lung syndrome diffuse alveolar hemorrhage pleurisy infection cardiopulmonary exercise testing osteopontin connective tissue diseases pulmonary involvement microvascular involvement nailfold capillaroscopy rheumatoid arthritis interstitial lung diseases CX3CL1/fractalkine CX3CR1 M1 macrophage M2 macrophage SKG mice heart failure 3D-echocardiography ventricular function outcome ventricular-arterial coupling antifibrotic agents COVID-19 IPF progressive fibrosing ILD UIP pharmacological interactions fibromyalgia gastrointestinal symptoms probiotic VSL#3® efficacy tolerability polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns